IMMUCELL CORPICCC

時価総額
$2813.6万
PER
2013年
12月31日
2019年
12月31日
2020年
12月31日
2021年
12月31日
2022年
12月31日
NET LOSS117,395-1,295,587-1,022,117-78,292-2,493,805
Depreciation414,3072222
Amortization of intangible assets2,89419,10419,10419,10419,104
Amortization of debt issuance costs-16,976102,7247,8417,658
Stock-based compensation31,359313,144253,135144,313266,244
(Gain) loss on disposal of property, plant and equipment-35,179-2,469-39,303-30,9637,334
Non-cash rent expense---15,320-10,716-28,476
Trade accounts receivable-704,867159,636897,428-935,629
Accrued interest income-27,753-27,258-495-
Inventory-442,494186,585-425,742997,4603
Prepaid expenses and other current assets-45,91773,74961,695-26,064110,858
Other assets-13,931-711-5850,513
Accounts payable and accrued expenses--88,711299,881245,760341,614
Net cash (used for) provided by operating activities-233,5111954,170-1,543,871
Purchase of property, plant and equipment597,6971434
Maturities of investment---3,449,000-996,000-
Proceeds from sale of property, plant and equipment--45,60015,29011,000
Net cash used for investing activities--3,403,360-2,569,939-1,597,359-3,964,274
Proceeds from public offering, net-8-4-
Proceeds from debt issuance--12400,0002
Debt principal repayments181,445861,34710768,271897,125
(Payments) net adjustments of debt issuance costs-----19,306
Proceeds from exercise of stock options21,7503911,69330,670
Net cash provided by financing activities-7241
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS--656,6443-4,393,906
Income taxes-3,5664,5815,1104,923
Interest expense-420,956481,408308,682338,516
Change in capital expenditures included in accounts payable and accrued expenses30,28474,052-43,895-44,998
Surrender of shares to exercise stock options---165,337-
Lease liability arising from obtaining right-of-use asset----1